LAVA Therapeutics NV (LVTX)
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
Address
YALELAAN 62
UTRECHT, P7 3584 CM
Founded
2016
Number of Employees
37
Website
http://www.lavatherapeutics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)